| Identification | Back Directory | [Name]
WB-4101 HCL | [CAS]
613-67-2 | [Synonyms]
06EJ
WB 4101
WB-4101 HCL
2-[2-(2,6-Dimethoxyphenoxy)ethylaminomethyl]-2,3-dihydro-1,4-benzodioxin
N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-benzodioxin-2-methanamine
2,3-dihydro-1,4-benzodioxin-2-ylmethyl-[2-(2,6-dimethoxyphenoxy)ethyl]amine
2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]methyl]-2,3-dihydro-1,4-benzodioxin
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
1,4-Benzodioxin-2-methanamine, N-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
N-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-2-(2,6-dimethoxyphenoxy)ethanamine | [Molecular Formula]
C19H23NO5 | [MOL File]
613-67-2.mol | [Molecular Weight]
345.39 |
| Hazard Information | Back Directory | [Definition]
ChEBI: N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine is a benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist. It has a role as an alpha-adrenergic antagonist. It is a benzodioxine, a secondary amino compound and an aromatic ether. It is a conjugate base of a N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanaminium(1+). | [Biological Activity]
α 1A -adrenergic selective antagonist. Also available as part of the α 1 -Adrenoceptor Tocriset™ . |
|
|